Search results for "FLUCONAZOLE"

showing 7 items of 47 documents

A multicenter, randomized trial of posaconazole (POS) vs fluconazole (FLU) or itraconazole (ITZ) for prophylaxis of invasive fungal infections (IFIs)…

2006

Posaconazolemedicine.medical_specialtyTransplantationAcute myelogenous leukemia (AML)Itraconazolebusiness.industryvirusesvirus diseasesIntensive chemotherapyHematologymedicine.diseaselaw.inventionRandomized controlled triallawInternal medicineImmunologymedicinebusinessFluconazolemedicine.drugBiology of Blood and Marrow Transplantation
researchProduct

Posaconazole (POS) vs fluconazole (FLU) for prophylaxis of invasive fungal infections (IFIs) in allogeneic hematopoietic stem cell transplant (HSCT) …

2006

TransplantationPosaconazolebusiness.industryHematologyrespiratory systemmedicine.diseaseGraft-versus-host diseaseMulticenter trialImmunologymedicineAllogeneic hematopoietic stem cell transplantbusinessFluconazolemedicine.drugBiology of Blood and Marrow Transplantation
researchProduct

208: Impact of posaconazole (POS) vs fluconazole (FLU) on cyclosporine (CsA) and tacrolimus (TAC) dosing in hematopoietic stem cell transplant (HSCT)…

2007

TransplantationPosaconazolebusiness.industryHematopoietic stem cellHematologybiochemical phenomena metabolism and nutritionbacterial infections and mycosesTacrolimusmedicine.anatomical_structureImmunologyMedicineDosingbusinessHost diseaseFluconazolemedicine.drugBiology of Blood and Marrow Transplantation
researchProduct

Safety of micafungin in prospective and retrospective clinical trials

2012

Summary Managing fungal diseases remains a major challenge for clinicians despite the improved armamentarium of antifungal agents. This review identified 19 publications reporting safety data on micafungin. Two of these publications were spin off publications, the remaining 17 (15 prospective, two retrospective) were included in the main assessment. Major adverse events reported which occurred in more than 2% in the study populations were infusion-related, gastro-intestinal and hepatic (LFT parameters elevations). Micafungin demonstrated significantly less renal events compared with liposomal amphotericin B and less hepatic events compared with voriconazole. Compared with fluconazole no sig…

VoriconazolebiologyEchinocandinbusiness.industryMicafunginDermatologyGeneral Medicinebacterial infections and mycosesbiology.organism_classificationInfectious DiseasesImmunologymedicineChillsmedicine.symptombusinessAdverse effectCandida albicansEchinocandinsFluconazolemedicine.drugMycoses
researchProduct

Prophylactic Fluconazole andCandida kruseiInfections

1992

biologybusiness.industryCandida kruseimedicineGeneral Medicinebiology.organism_classificationbusinessFluconazoleMicrobiologymedicine.drugNew England Journal of Medicine
researchProduct

The Effects of Oregano Oil on Fungal Infections Associated with Metabolic Syndrome

2020

International audience; This study aims to compare the evolution of mycosis associated with metabolic syndrome under allopathic treatment compared to phytotherapy using oregano essential oil. The study was conducted over a period of 6 months, on a total of 72 patients diagnosed with fungal infections associated with metabolic syndrome. The patients were divided into 3 groups, depending on the administered treatment: group 1: 24 patients who received allopathic treatment; group 2: 24 patients who received oregano oil treatment; group 3: control, which did not undergo any antifungal treatment. All three groups were subjected to specific diet therapy for mycosis. The patients were initially ev…

medicine.medical_specialtyDiet therapyItraconazoleMaterials Science (miscellaneous)010402 general chemistry01 natural sciencesGastroenterologyGeneral Biochemistry Genetics and Molecular Biologylaw.inventionFungal infectionsOregano oillawInternal medicineMaterials ChemistrymedicineGeneral Pharmacology Toxicology and PharmaceuticsMycosisProcess Chemistry and TechnologyGeneral EngineeringGeneral ChemistryGeneral Medicinemedicine.disease3. Good health0104 chemical sciencesNystatinTolerabilityMetabolic X syndrome[SDE]Environmental SciencesMetabolic syndromePhytotherapyFluconazolemedicine.drug
researchProduct

Posaconazole vs Standard Azole (FLU/ITRA) Therapy for Prophylaxis of Invasive Fungal Infections (IFIs) among High-Risk Neutropenic Patients: Results …

2005

Abstract Background: Patients with severe and prolonged neutropenia are at high-risk of developing life-threatening IFIs. Despite current treatment option, IFIs are difficult to treat and frequently associated with high mortality rates. Antifungal prophylaxis has shown benefits in high-risk populations and is a standard practice in many institutions. We compared Posaconazole (POS), a new broad-spectrum triazole, vs Standard Azoles for the prevention of IFIs in patients with a new diagnosis or first relapse of acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) being treated with intensive chemotherapy. Methods: Patients in this randomized, evaluator-blinded, active controlled…

medicine.medical_specialtyPosaconazoleItraconazolebusiness.industryImmunologyCell BiologyHematologyNeutropeniamedicine.diseaseBiochemistrySurgeryDiscontinuationTolerabilityInternal medicineMulticenter trialmedicineAdverse effectbusinessFluconazolemedicine.drugBlood
researchProduct